Design and generation of recombinant rabies virus vectors

被引:0
|
作者
Fumitaka Osakada
Edward M Callaway
机构
[1] Systems Neurobiology Laboratories,
[2] The Salk Institute for Biological Studies,undefined
来源
Nature Protocols | 2013年 / 8卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Rabies viruses, negative-strand RNA viruses, infect neurons through axon terminals and spread trans-synaptically in a retrograde direction between neurons. Rabies viruses whose glycoprotein (G) gene is deleted from the genome cannot spread across synapses. Complementation of G in trans, however, enables trans-synaptic spreading of G-deleted rabies viruses to directly connected, presynaptic neurons. Recombinant rabies viruses can encode genes of interest for labeling cells, controlling gene expression and monitoring or manipulating neural activity. Cre-dependent or bridge protein–mediated transduction and single-cell electroporation via the EnvA-TVA or EnvB-TVB (envelope glycoprotein and its specific receptor for avian sarcoma leukosis virus subgroup A or B) system allow cell type–specific or single cell–specific targeting. These rabies virus–based approaches permit the linking of connectivity to cell morphology and circuit function for particular cell types or single cells. Here we describe methods for construction of rabies viral vectors, recovery of G-deleted rabies viruses from cDNA, amplification of the viruses, pseudotyping them with EnvA or EnvB and concentration and titration of the viruses. The entire protocol takes 6–8 weeks.
引用
收藏
页码:1583 / 1601
页数:18
相关论文
共 50 条
  • [31] Generation of lentivirus vectors using recombinant baculoviruses
    H P Lesch
    S Turpeinen
    E A Niskanen
    A J Mähönen
    K J Airenne
    S Ylä-Herttuala
    Gene Therapy, 2008, 15 : 1280 - 1286
  • [32] CHARACTERIZATION OF RABIES VIRUS GLYCOPROTEIN EXPRESSED BY RECOMBINANT BACULOVIRUS
    TUCHIYA, K
    MATSUURA, Y
    KAWAI, A
    ISHIHAMA, A
    UEDA, S
    VIRUS RESEARCH, 1992, 25 (1-2) : 1 - 13
  • [33] EFFICACY STUDIES ON A CANARYPOX-RABIES RECOMBINANT VIRUS
    TAYLOR, J
    TRIMARCHI, C
    WEINBERG, R
    LANGUET, B
    GUILLEMIN, F
    DESMETTRE, P
    PAOLETTI, E
    VACCINE, 1991, 9 (03) : 190 - 193
  • [34] Application of Recombinant Rabies Virus to Xenopus Tadpole Brain
    Faulkner, Regina L.
    Wall, Nicholas R.
    Callaway, Edward M.
    Cline, Hollis T.
    ENEURO, 2021, 8 (04)
  • [35] Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein
    Sun, Lina
    Chen, Zhe
    Yu, Li
    Wei, Jingshuang
    Li, Chuan
    Jin, Jing
    Shen, Xinxin
    Lv, Xinjun
    Tang, Qing
    Li, Dexin
    Liang, Mifang
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2012, 96 (02) : 357 - 366
  • [36] Oral vaccination of dogs with recombinant rabies virus vaccines
    Rupprecht, CE
    Hanlon, CA
    Blanton, J
    Manangan, J
    Morrill, P
    Murphy, S
    Niezgoda, M
    Orciari, LA
    Schumacher, CL
    Dietzschold, B
    VIRUS RESEARCH, 2005, 111 (01) : 101 - 105
  • [37] Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein
    Sun, Lina
    Wei, Jingshuang
    Qu, Jing
    Li, Dexin
    Liang, Mifang
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [38] Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein
    Lina Sun
    Zhe Chen
    Li Yu
    Jingshuang Wei
    Chuan Li
    Jing Jin
    Xinxin Shen
    Xinjun Lv
    Qing Tang
    Dexin Li
    Mifang Liang
    Applied Microbiology and Biotechnology, 2012, 96 : 357 - 366
  • [39] Custom adeno-associated virus capsids: The next generation of recombinant vectors with novel tropism
    Muzyczka, N
    Warrington, KH
    HUMAN GENE THERAPY, 2005, 16 (04) : 408 - 416
  • [40] Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach
    Zhang, XW
    Li, CY
    MOLECULAR THERAPY, 2001, 3 (05) : 787 - 792